Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)

PHASE3CompletedINTERVENTIONAL
Enrollment

5,920

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Malaria,FalciparumChildren, Only
Interventions
BIOLOGICAL

RABIPUR®

Year 1 (2017) Three doses of rabies vaccine (April, May, June) Year 2 and 3 (2018/19) One dose of Hepatitis A vaccine (June)

BIOLOGICAL

RTS,S/AS01

Year 1 (2017) Three doses of RTSS/AS01 (April, May, June) Year 2 and 3 (2018/19) One booster dose of RTSS/AS01 (June)

DRUG

SMC with SP+AQ

Year 1, 2 and 3(2017/18/19) Four cycles of SMC (SP+AQ) during the malaria transmission season One cycle of SMC for children above one year of age consisting of sulphadoxine - pyrimethamin (SP) 500mg/25 mg, and amodiaquine (AQ) 150mg on day 1, and AQ 150mg on days 2 and 3. Infants will receive half of these doses.

DRUG

SMC placebo

Year 1, 2 and 3(2017/18/19) Four cycles of SMC placebo during the malaria transmission season

Trial Locations (2)

Unknown

Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest, Ouagadougou

Malaria Research & Training Center, Bamako

All Listed Sponsors
collaborator

Malaria Research and Training Center, Bamako, Mali

OTHER

collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03143218 - Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) | Biotech Hunter | Biotech Hunter